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Summary 1992, 1994). More than 50 mitochondrial point muta-
tions have been reported, most commonly involvingWe report the clinical, biochemical, and genetic investi-
tRNA, particularly that for leucine (UUR) (Kadenbachgation of a patient with a severe mitochondrial encepha-
et al. 1995). Different tRNA mutations can give rise tolomyopathy. Genetic studies identiﬁed a novel, hetero-
widely differing phenotypes, but it is evident that noplasmic tRNA mutation at nt 10010. This TrC
one phenotype is speciﬁc for any one tRNA mutation.transition is located in the DHU loop of mitochondrial
Pathological mitochondrial tRNA mutations are almosttRNAGly. In skeletal muscle, it was present at lower lev-
always heteroplasmic—that is, both mutant and wildels in cytochrome c oxidase (COX)–normal (87.2%
type exist within the same individual and, usually,{ 11%) compared with COX-deﬁcient ﬁbers (97.3%
within the same tissue. Levels of heteroplasmy (i.e., the{ 2.6%); it was found in skin ﬁbroblasts and blood
proportion of mutant mtDNA) are often highest in tis-cells, but at lower levels of heteroplasmy (15% { 6%
sues that are postmitotic and are lowest in those thatand 17%{ 10%, respectively). A second, heteroplasmic
divide rapidly, presumably because dividing cells thattransition (ArG), at nt 5656, showed a different distri-
contain high levels of a mtDNA mutation are energeti-bution than the tRNAGly mutation, with very low levels
cally compromised and, therefore, at a selective disad-in skeletal muscle (õ3%) but higher levels in blood
vantage. The situation is different in cells dividing in(22.7% { 3%) and skin ﬁbroblasts (21% { 2%). These
culture where levels of heteroplasmy can remain stable,transitions were followed both in vivo, by repeat biopsy
decline, or, indeed, increase, possibly inﬂuenced by nu-and blood sampling, and in vitro, by establishing pri-
clear background (Yoneda et al. 1992; Dunbar et al.mary cultures of myoblasts and skin ﬁbroblasts. Repeat
1995). The correlation between disease and level of mu-muscle biopsy showed a dramatic increase in COX-de-
tant mtDNA is complex and often deviates from theﬁcient ﬁbers, but not of the tRNAGly mutation. Indeed,
linear. In cell-culture experiments and in single muscleno signiﬁcant change in heteroplasmy was measured for
ﬁbers, however, the relationship between heteroplasmyeither substitution in muscle or blood. In vitro analysis
and the biochemical phenotype is more consistent, withgave very different results. The T10010C was not found
as little as 5%–10% wild-type mtDNA being sufﬁcientin cultured myoblasts, even at early passage. In uncloned
to rescue respiratory function (Chomyn et al. 1992).ﬁbroblasts, the T10010C was stable (Ç10%) for several
Although the ﬁnding of two different mtDNA mole-passages but then gradually was lost. In contrast, the
cules (mutant and wild type) is well recognized, the pres-A5656G rose progressively from 27% to 91%. In cloned
ence of two different, heteroplasmic changes in one indi-ﬁbroblasts, different combinations of both base-pair
vidual is not. Recently, Howell and colleagues identiﬁedchanges and wild type could be identiﬁed, conﬁrming
individuals with three base substitutions within the hyp-the presence of clonal, intracellular triplasmy.
ervariable region of the D-loop in a large pedigree hav-
ing Leber hereditary optic neuropathy (Howell et al.Introduction
1996). Single base changes and length variations within
mtDNA point mutations are well-recognized causes of the D-loop also have been found in controls and individ-
disease, particularly within the nervous system (Wallace uals carrying a polymorphism at nt 16189 (Bendall and
Sykes 1995; Morten et al. 1995). In addition, D-loop
changes also have been identiﬁed in individuals who
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carry mtDNA rearrangements (Brockington et al. 1993).1997.
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deleted molecules contained the mutant 3243 allele, 1,800 U/liter and normal (õ170 U/liter). Electromyelog-
raphy showed changes compatible with a myopathy.which also was present in a subset of undeleted mole-
cules. Whether more than one species of mtDNA was Muscle biopsy was performed at this stage and con-
ﬁrmed a mitochondrial myopathy with Ç30% raggedcontained within the same cell was, unfortunately, not
determined (Ohno et al. 1996). red ﬁbers (RRF) and Ç21% COX-deﬁcient ﬁbers.
She has continued to deteriorate, with progressiveWe report here the investigation of a young woman
with a clinical picture of severe mitochondrial encepha- spastic ataxia and further seizures. Sequential CT brain
scans have shown repeated cerebral infarction and pro-lomyopathy in whom we identiﬁed two heteroplasmic
base changes, one of which is a novel, pathological mu- gressive atrophy. She has also developed glucose intoler-
ance. A second muscle biopsy was performed in 1995tation involving mitochondrial tRNAGly. To our knowl-
edge, there have been no previous reports identifying and showed Ç50% RRF and Ç85% COX-deﬁcient ﬁ-
bers.more than one heteroplasmic base change outside the
D-loop. Variation in levels of both base substitutions Skin and Muscle Biopsy/Culture
was followed in vivo and in vitro. Our results also show
Skin and quadriceps-muscle biopsies were per-
that cells may be triplasmic, carrying at least three differ-
formed under local anesthesia, with the informed con-
ent mtDNA genotypes.
sent of the patient. The ﬁrst muscle biopsy was done in
February 1990, the second in May 1995. Histological/
Case, Material, and Methods histochemical analysis was performed on each skeletal
muscle biopsy (Johnson et al. 1993), and the respira-Case Report
tory chain–complex activities were assessed on mito-
This 33-year-old female presented at age 20 years with
chondria fractions isolated both from the ﬁrst muscle
severe generalized headache, nausea, and vomiting after
biopsy (Bindoff et al. 1991) and from skin ﬁbroblasts
the consumption of a moderate amount of alcohol. She
(Lowerson et al. 1992).
had a brother with epilepsy and four healthy children.
Tissue CultureShe was of short stature and of low IQ. Examination of
the limbs showed normal tone and power but exagger- Myoblast cultures were established from the ﬁrst
biopsy and were grown in standard media (Blau andated reﬂexes with ﬂexor plantars. Investigation showed
mildly abnormal liver enzymes (raised g glutamyl trans- Webster 1981) plus 50 mg uridine/ml and 110 mg py-
ruvate/ml. At Ç80% conﬂuency, the myoblasts wereferase and aspartate aminotransferase), acellular cere-
brospinal ﬂuid (CSF) with raised protein (0.5 g/liter), harvested, with half being replated and half being used
for DNA extraction. Fibroblasts were grown in the pres-and an electroencephalogram (EEG) revealing a slow
background with focal seizure discharges from the left ence of uridine and pyruvate until they were Ç90%
conﬂuent. After being harvested, one-third of the cellstemporal lobe. Her symptoms resolved, but she was re-
admitted 10 d later with choreoathetoid movements ini- were replated, whereas DNA was extracted from the
remaining cells. The replating thereby constituted onetially involving her right and then her left arm and then
both legs. Computed-tomography (CT) brain scan was passage. For cloning, ﬁbroblasts (from passage 5) and
myoblasts (from passage 5) either were subjected to se-normal, as were serum copper, ceruloplasmin, and thy-
roid function. She was treated with tetrabenazine, and rial dilutions in 96-well microtiter plates or were diluted
into petri dishes, until the presence of single cells couldthe movements gradually subsided.
Three years later she returned, suffering from unsteadi- be conﬁrmed. Myoblast clones were conﬁrmed by fusion
to myotubes, on serum starvation.ness, episodic loss of consciousness, and leg cramps, all
of which had been present for several months. She had DNA Analysis
mild tandem ataxia, dystonic posturing of the right hand,
Total genomic DNA from skeletal muscle, blood leu-
a mild symmetrical tetraparesis, and both dysdidokok-
kocytes, and cultured cells (myoblasts and ﬁbroblasts)
inesis and dysmetria of the upper limbs. Liver enzymes
was extracted according to standard methods. Regions
were again elevated, and an EEG showed generalized
of the mitochondrial genome were ampliﬁed by use of
spike-and-wave discharges. Further CT brain scan, copper
PCR and were puriﬁed through a Centricon-100 ﬁlter.
studies, and CSF analysis were all normal. She was treated
Biotinylated primers facilitated the production of sin-
with anticonvulsants but did not attend review.
gle-strand template (DYNAL magnetic beads), which
Deﬁnitive investigation was performed in 1990. At
was subjected to dideoxy-chain terminating DNA se-
this time she had developed bilateral optic atrophy and
quence analysis following standard procedures (Jack-
right-sided sensorineural hearing loss, in addition to a
son et al. 1994).
mild, left hemiparesis and an ataxic, spastic gait. Serum
RFLP Analysisbicarbonate was low (15 mM; normal 22–29 mM), and
serum lactate was elevated (5.3 mM; normalõ1.7 mM). 10010 heteroplasmy.—A 1,252-bp mtDNA fragment
spanning bp 8911–10163 (Anderson et al. 1981) wasCreatine kinase activity varied and ranged between
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phorImager cassette. For quantiﬁcation of heteroplasmy,
we used the ImageQuant software package (Molecular
Dynamics) after normalizing the 416-, 263-, and 153-bp
fragments for deoxycytosine content.
5656 heteroplasmy.—A 140-bp mtDNA fragment
spanning bp 5538–5677 was ampliﬁed from total DNA
samples by use of the primers 5-CAC TAT AGC TAG
CCC TCA GTA AGT TGC AAT AC-3 (sense) and
5-GTT TAA GTC CCA TTG GGC TAG-3 (antisense).
Both primers are mutated to create novel NheI sites
(underlined). The restriction site within the sense-primer
site acts as an internal control, whereas the antisense
primer carries an ArG missense mutation ﬁve bases
from the 3 terminus, which creates an NheI site only
when the A5656G transition is present. After an initial
denaturation step (8 min at 94C), PCR ampliﬁcation
was performed for 29 cycles (1 min at 94C, 1 min at
60C, and 1 min at 72C); a ﬁnal hot cycle was done as
detailed above, and the product was subjected to NheI
digestion for several hours at 37C. NheI produces two
products—129 and 11 bp—from the wild-type mtDNA
fragment, but, in the presence of the A5656G mutation,
a novel restriction site is produced, and three frag-
ments—109, 20, and 11 bp—are generated. Digested
DNA was electrophoresed through a 16% nondenatur-
ing gel, and heteroplasmy was quantiﬁed as for the
T10010C transition after the 129- and 109-bp frag-
ments were normalized for deoxycytosine content.
Figure 1 Cytochrome c oxidase activity of single muscle ﬁbers.
Single-Fiber and Single-Cell PCRTen-micrometer transverse sections were subjected to microspectro-
photometric analysis in sequential muscle-biopsy samples taken Transverse sections (30 mm) of frozen muscle were
from the patient. Two hundred ﬁbers from each thin section are mounted on gelatin-coated slides and were double-
scored for COX activity, and ﬁbers are represented as a function of
stained for cytochrome c oxidase and succinate dehydro-activity and ﬁber type. Limits for COX-deﬁcient activities and the
genase activity, as described elsewhere (Weber et al.mean COX activity ({SD) are shown for each ﬁber type (Johnson
et al. 1993). The two biopsies were performed 63 mo apart. The 1997). COX-deﬁcient ﬁbers appear blue, whereas COX-
results show a shift in ﬁber type, mainly to type I, and demonstrate normal ﬁbers are brown, enabling each ﬁber to be care-
marked loss of cytochrome oxidase activity, such that the majority fully identiﬁed and isolated with a borosilicate micro-
of ﬁbers fall under the lower limit of the normal range shown by
capillary under an inverted microscope. Fibers werethe double arrow (RÉr)
placed in 20 ml of dH20 and DNA isolated by either of
the following two protocols: (1) ﬁbers were boiled for
5 min before being added directly to the PCR reaction;
ampliﬁed from total DNA samples by use of the primers or (2) the dH20 was removed and the cells were lysed
5-GGT GGA TCT TTC TAT GTA GGC-3 (sense) and (200 mM KOH:50 mM DTT, for 1 h at 65C) and
5-TTA CCA CAA GGC ACA CCT AC-3 (antisense). neutralized (200 mM HCl:900 mM Tris-HCl pH 8.3)
The PCR proﬁle consisted of an initial step of melting (4 before being added to the PCR reaction. DNA also was
min at 94C), followed by 29 cycles of 1 min at 94C, 1 extracted from single myoblasts and ﬁbroblasts, for PCR
min at 58C, and 2 min at 72C and a ﬁnal cycle of ampliﬁcation using these techniques. Ampliﬁcation was
ampliﬁcation that contained 10 mCi of 32P dCTP (3,000 as detailed in the RFLP Analysis section above.
Ci/mol). After precipitation, 25,000 cpm of DNA (Ceren- For estimation of clonal triplasmy, DNA was isolated
kov) were digested with 10 units of RsaI (Boehringer from a fraction of cells grown from a single clone. This
Mannheim) for 6 h at 37C. The restriction endonuclease DNA sample was then assessed for levels of both alleles,
RsaI normally would generate four fragments—748, as detailed above.
263, 153, and 88 bp— from this region of mtDNA, but,
Resultswith the T10010C transition, a site is lost, leaving three
Histology/Biochemistryfragments—748, 416, and 88 bp. Digested DNA was
electrophoresed through a 3.5% nondenaturing poly- Histochemical analysis readily identiﬁed the three
main ﬁber types, andmicrospectrophotometric measure-acrylamide gel which was dried and exposed to a Phos-
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Table 1
Biochemical Analysis of Respiratory Chain–Complex Activities
SKELETAL MUSCLE FIBROBLASTS
Patient Control Patient Control
Complex I (nmol NADH oxidized/min/mg protein) 42 243 { 59 (n Å 20) 25.6 39.8 { 16.6 (n Å 9)
Complex II (nmol DCPIP reduced/min/mg protein) 250 304 { 87 (n Å 20) 42.7 41.1 { 15.7 (n Å 8)
Complex IV (k/s/mg protein)a .9 2.19 { .29 (n Å 10) .154 .214 { .05 (n Å 9)
Complex I/complex II ratio .17 .8 { .34 (n Å 20) .6 1.09 { .6 (n Å 8)
NOTE.—There is loss of activity of both complex I and complex IV in skeletal muscle, but not in ﬁbroblast mitochondrial fractions.
a Expressed as an apparent ﬁrst-order rate constant.
ment of enzyme activity showed a dramatic change, in proportion of type I ﬁbers relative to other ﬁber types
and a major increase in COX-deﬁcient ﬁbers (21% vs.both the quantity and distribution of COX-deﬁcient ﬁ-
bers, between the two biopsies (ﬁg. 1). In the ﬁrst biopsy, 85%; ﬁg. 1). Biochemical measurement of respiratory-
chain activity, by use of mitochondrial fractions fromthe COX-deﬁcient ﬁbers were predominantly type I, and
a clearly bimodal distribution can be seen in this ﬁber the ﬁrst muscle biopsy, showed low complex I and IV
activity (table 1). Respiratory-chain activity was normaltype. Five years later there were both an increase in the
in mitochondrial fractions from ﬁbroblasts (table 1).
Genetic Studies
Southern blot analysis ruled out the presence of an
mtDNA rearrangement. Each tRNA gene and various
protein-coding regions of the mtDNA were sequenced.
A novel TrC transition at nt 10010 was found. This is
predicted to lie within a conserved region of the DHU
loop of the tRNAGly gene. No other mutation or poly-
morphism was apparent in skeletal muscle mtDNA, and
initial DNA sequence analysis revealed little, if any,
mtDNA wild type for the 10010 allele (ﬁg. 2A). Al-
though most pathological mitochondrial tRNA muta-
tions are heteroplasmic, different mtDNA species may
segregate during development or may not become ﬁxed
in rapidly dividing tissue. We looked, therefore, at blood
and ﬁbroblasts, for the presence of the T10010C transi-
tion. Figure 2A shows that peripheral blood leukocytes
and ﬁbroblasts are heteroplasmic for the transition but
carry mainly the wild-type allele, explaining why the
biochemical defect was not detectable in ﬁbroblasts (ta-
ble 1).
Sequence analysis of both ﬁbroblast and leukocyte
mtDNA revealed a second transition (ArG), at nt 5656,
which was also heteroplasmic (ﬁg. 2B). This residue is
the single base pair that lies between two mitochondrial
tRNA genes—tRNAAla and tRNAAsn—close to the ori-
gin of L-strand replication. To quantify the levels of both
mutations in the various tissues, primers and restriction
endonucleases were chosen to facilitate last-cycle-hotFigure 2 mtDNA sequence analysis of various tissues. A, Analy-
sis of skeletal muscle DNA, clearly showing the TrC transition at nt PCR and RFLP analysis. The approach is shown sche-
10010. Heteroplasmy for the TrC transition can be seen in mtDNA matically in ﬁgure 3A, and the techniques are detailed in
from ﬁbroblasts and leukocytes. DNA isolated from a control contains the Case, Material, and Methods section. The T10010Cno similar transition. B, Second heteroplasmic ArG transition at nt
transition is close to 90% levels in homogenate from5656, present in the patient’s ﬁbroblast and leukocyte DNA but absent
in her skeletal muscle sample. both skeletal muscle biopsies, whereas the A5656G tran-
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(table 2). Despite the fact that the proportion of COX-
deﬁcient ﬁbers increased dramatically between the two
biopsies, the overall percentage of T10010CmtDNA did
not differ markedly (92% vs. 88%; table 2). In addition,
there was little change in heteroplasmy, for either allele,
between successive blood samples (table 2).
The presence of two heteroplasmic mtDNA transi-
tions in one individual raised the possibility that the
patient has as many as four different mtDNA molecules:
wild type, A5656G transition, T10010C transition, and
a molecule containing both transitions. To investigate
this and the question of whether mtDNA heteroplasmy
was inter- or intracellular, primary cultures of ﬁbro-
blasts and myoblasts were established. In the patient’s
myoblasts, the A5656G transition remained constant for
a period, before declining (from 26% to 8%, between
passage 4 and passage 21); the T10010C, however, was
absent from the patient’s myoblasts in culture, even at
the earliest passage (passage 4) analyzed. Quantiﬁcation
of A5656G and T10010C heteroplasmy in cultured ﬁ-
broblast is shown in ﬁgure 4. The data show a dramatic
increase, in the level of the A5656G transition, between
passage 5 and passage 10 (ﬁg. 4). The level of T10010C
remains stable until passage 17 and then declines, sug-
gesting that the increase in A5656G is at the expense of
the wild type.
Cells were removed from the ﬁbroblast (passage 5)
and myoblast (passage 5) lines and were cloned and
expanded for several divisions before being assessed for
each mtDNA transition. As illustrated in table 3, the
vast majority of ﬁbroblast clones showed intracellular
heteroplasmy; of the 25 clones and single cells assayed,
only 6 contained a single allele, all being apparentlyFigure 3 RFLP analysis of PCR-ampliﬁed mtDNA from various
tissues. A, Analysis of DNA for the nt 10010 allele. A 1,252-bp frag- homoplasmic for A5656G and wild type for T10010C.
ment was ampliﬁed from two samples of blood leukocytes (BL1 and In four clones, however, the combined level of both
BL2), ﬁbroblasts (F), and both skeletal muscle biopsies (SM1 and transitions was õ100%, making them triplasmic. In no
SM2). The two blood and muscle samples were taken 5 years apart
tissue type was the sum of both transitions ú100%,(see text). Digestion with RsaI gives four fragments, shown schemati-
although several clones appeared to exceed this number,cally on the right-hand side the panel. The presence of the TrC transi-
tion at bp 10010 removes the site that permits digestion of the 416-bp suggesting the presence of a fourth molecule containing
fragment to 263- and 153-bp fragments. A high level of the T10010C both transitions; however, preliminary experiments have
transition is apparent in the skeletal muscle samples but not in blood been unable to detect this molecule (data not shown).
cells or ﬁbroblasts. DNA from control samples is shown both in the
No myoblast clones harbored any detectable T10010Ccut (CON CUT) and uncut (CON UNCUT) forms. B, Analysis of
transition, but, again, they demonstrated unequivocalampliﬁed DNA for the nt 5656 allele. A 140-bp fragment was isolated
from the same types of tissues as are shown in panel A. Digestion intracellular heteroplasmy for the A5656G allele (ta-
with NheI generates two fragments (11 and 129 bp) in the presence ble 3).
of the wild-type allele and three fragments (11, 20, and 109 bp) in
the presence of the A5656G transition. The two smaller fragments
are not shown on the gel. Discussion
The clinical symptoms, histological ﬁndings, and ab-
normal activities of complexes I and IV in the skeletalsition is õ3% in both (table 2). Single-ﬁber analysis of
the ﬁrst biopsy shows that COX-normal ﬁbers had a muscle mitochondrial respiratory chain are consistent
with this patient having a pathological mtDNA muta-lower level of the T10010C transition than the COX-
deﬁcient ﬁbers, which had a mean percentage of ú95%. tion. The following criteria strongly suggest that the
T10010C transition is indeed that mutation: (i) the mu-In contrast, the A5656G transition was present at ex-
tremely low levels, although it appears to be lower in tation is heteroplasmic, has not been reported elsewhere,
and is absent in all controls analyzed; (ii) the mutationCOX-deﬁcient ﬁbers compared with COX-normal ﬁbers
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Table 2
Distribution and Change, with Time, of T10010C and A5656G Transitions
DISTRIBUTION
(%)
In Tissuea
In Single Muscle Fibers
Skeletal Skeletal Peripheral Blood Peripheral Blood
Muscle 1 Muscle 2 Fibroblasts Leukocytes 1 Leukocytes 2 COX Normal COX Deﬁcient
T10010C 92 { 3 (n Å 4) 88 { 5 (n Å 4) 15 { 6 (n Å 4) 17 { 10 (n Å 4) 12 { 6 (n Å 4) 87.2 { 11b (n Å 17) 97.3 { 2.6c (n Å 22)
A5656G 2.3 { 1 (n Å 4) 1.2 { 1 (n Å 4) 21 { 2 (n Å 5) 28 { 3 (n Å 6) 27 { 1 (n Å 4) 2.3 { 1.9 (n Å 15) õ1 (n Å 23)
a Designations ‘‘1’’ and ‘‘2’’ denote ﬁrst and second biopsies, respectively, which were taken 5 years apart.
b Range 60–98.
c Range 95–100.
is present in very high levels (ú90%) in skeletal muscle slow; but neither are under neurological review. We did
but is present at low levels in leukocytes and ﬁbroblasts manage to obtain blood from an older, unaffected sister,
(õ25%), a ﬁnding consistent with biochemical data and this showed neither of the transitions identiﬁed in
showing low activity of complexes I and IV in skeletal the patient (data not shown).
muscle but not in ﬁbroblast mitochondria; (iii) single- The two muscle-biopsy samples, taken 5 years apart,
ﬁber analysis shows that the level of the T10010C transi- showed a dramatic increase in COX-deﬁcient ﬁbers, but
tion is higher in COX-deﬁcient ﬁbers than in COX- no increase in overall mutant load was detectable in
normal ﬁbers; and (iv) the T10010C mutation is pre- homogenate. Most heteroplasmic defects of the mito-
dicted to fall within a highly conserved region of the chondrial genome are associated with progressive medi-
DHU loop of an mtDNA-encoded tRNA gene, a posi- cal deterioration, as is the case with this patient. It has
tion that is highly likely to disrupt its function and to been shown elsewhere that deleted mtDNA can increase
interfere with mitochondrial protein synthesis. with time (Larsson et al. 1990), and, more recently, we
The clinical features seen in this patient once again have shown that this also is possible for an mtDNA
demonstrate the diversity of mitochondrial disease. She point mutation (Weber et al. 1997). Work in vitro shows
presented with an encephalopathy that may have been that mutated mtDNAmay increase, decrease, or, indeed,
precipitated by alcohol and she went on to develop sei- stay the same; and it is postulated that this may reﬂect,
zures, a movement disorder, and a progressive ataxic, in part, the nuclear background (Yoneda et al. 1992;
spastic tetraparesis. It is likely that she also has liver Dunbar et al. 1995). One possible explanation of our
involvement and that there is progressive cognitive im- observations is that most organelles in the earlier biopsy
pairment. One brother has been diagnosed as having were heteroplasmic, with the wild-type mtDNA able to
epilepsy, and another brother is thought to be mentally compensate for the mutant molecule. The recessive na-
ture of mitochondrial tRNA mutations is well docu-
mented. After 5 years, mtDNA may have segregated to
near homoplasmy between organelles in the same ﬁber
(on the assumption that mitochondria remain discrete
and do not fuse), allowing only a small subset of wild
type–containing mitochondria to function correctly.
These data are not necessarily consistent with a replica-
tive advantage for the mutant genome, since segregation
may have occurred stochastically. A second explanation,
however, is that there has been a small but generalized
increase in mutant load, sufﬁcient to cross the threshold
and cause COX deﬁciency. This increase may have been
masked by the inherent error in quantiﬁcation and, al-
Figure 4 Histogram showing the levels of both transitions in though small, may have been sufﬁcient to exceed the
uncloned cultured skin ﬁbroblasts. T10010C and A5656G are present protective capacity of intramitochondrial wild-type
at similar levels in the earlier passages, but, between passages 5 and mtDNA molecules, which is calculated to be Ç6%–10, the amount of A5656G increases dramatically. Since the level of
10% in cell-culture experiments (Chomyn et al. 1991;T10010C remains stable, at least initially, this increase must be at the
expense of the wild-type molecule. Boulet et al. 1992).
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Table 3
Analysis of Cultured Fibroblasts and Muscle Cells, for A5656G and T10010C Transitions
HETEROPLASMYa
(%)
A5656G T10010C TOTAL NO. OF CLONES
Fibroblasts:
Triplasmic:
C6/C 58 30
D5/C 54 12
4
E6/C 16 45
F5/C 32 8
Other heteroplasmic:b
B2/C 90 10
F4/C 84 9
C2/C 97 4
C6/B 35 ND
C8/B 48 ND
G2/B 52 ND
B8/C 43 56
E3/C 78 31
15
E7/C ND 57
E8/C 62 ND
SF14 79 0
SF17 74 ND
SF18 71 ND
SF19 4 95
SF20 29 66
Clones:
Homoplasmic ﬁbroblast:b
100 0 6
0 100 0
0 0 0
Heteroplasmic myoblast:
C4/B 23 0
D6/A 38 0
B5/B 9 0 5
E11/B 9 0
G10/B 21 0
Homoplasmic myoblast:
100 0 0
0 0 7
NOTE.—In four clones there was clear evidence of triplasmy, with varying amounts of both transitions
and wild-type mtDNA. In a further ﬁve clones and two single cells isolated from clonal ﬁbroblast lines, the
analysis showed that the combined level of both transitions came to Ç100%, suggesting that very little or
no wild-type genome is present. Six ﬁbroblast clones were homoplasmic for the A5656G transition, but we
identiﬁed no lines that were homoplasmic for the T10010C transition. Analysis of cultured myoblasts
showed ﬁve that were heteroplasmic for A5656G and wild type and seven that were homoplasmic wild
type.
a ND Å not done. 100% and 0% denote that no detectable levels of heteroplasmy could be determined
within the limits of experimental error.
b SF Å single ﬁbroblast.
The absence of the T10010C transition in cultured since the high level of the mutation in muscle homogenate
suggests that the vast majority of original muscle cellsmyoblasts is noteworthy: we were unable to detect any,
even when using the sensitive technique of last-cycle-hot contained signiﬁcant levels of mutation. If myoblasts and
satellite cells come from a common progenitor, then thePCR at the earliest stage of analysis (passage 4). Although
it is feasible that satellite cells present in the biopsy did latter should also contain the mutation. An alternative
explanation is that cells destined to be mature skeletalcontain high levels of the T10010C mutation but were
unable to thrive in culture, we feel that this is unlikely, muscle and satellite cells come from different embryologi-
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cal lineages (Schultz and McCormick 1993). Support for must have occurred, cells have not tended toward intra-
cellular homoplasmy simply by random drift. These datathis hypothesis comes from (1) our recent observations
in another patient with a selective mitochondrial myopa- suggest either that there may be a mechanism in vivo
that selects for or maintains intracellular heteroplasmythy, in whom the mtDNA mutation was present at high
level in skeletal muscle and absent from satellite cells or that there is indeed a more stringent mode of replica-
tion and partitioning than elsewhere has been reported(Weber et al. 1997), and (2) the patient reported by Shou-
bridge and colleagues (Fu et al. 1996). Given the wide- in vitro.
The presence of three forms of mtDNA in at leastspread nature of the clinical disease in our patient, we
feel that it is surprising that our analysis of satellite cells some ﬁbroblasts begs the following question: Is there
any evidence for a recombinant molecule containingfailed to identify the T10010C mutation. Nevertheless, if
this is indeed the case, then one intriguing therapy would both transitions, or did the individual transitions occur
independently and remain separate? Although recombi-be to encourage muscle degeneration, allowing subse-
quent regeneration from satellite cells containing substan- nation had been believed not to occur between mamma-
lian mtDNA molecules, recent studies have suggestedtial levels of wild-type mtDNA.
During our mtDNA analysis, we discovered a sec- that a mechanism for homologous recombination may
exist and that this may be important in mtDNA repairond, heteroplasmic, single base transition at nt 5656.
To our knowledge, this is the ﬁrst report of a patient (Thyagarajan et al. 1996). We were unable to show
unequivocally the presence of a molecule containingharboring more than one heteroplasmic base substitu-
tion outside the D-loop. The A5656G was present at both transitions either in vivo or in cultured ﬁbroblasts,
although in two clones the quantiﬁcation of both transi-a very low level in skeletal muscle, an affected tissue;
thus we feel that it is highly unlikely to be the patholog- tions was ú100%. Since this increase may lie within the
bounds of experimental error, we cannot formally proveical mutation in this patient. This transition recently
has been reported in association with non–insulin-de- or disprove the presence of a recombinant molecule.
pendent diabetes (Thomas et al. 1996). Since it was
homoplasmic in these individuals, it is likely to be a
Acknowledgmentsbenign, silent polymorphism.
The two transitions identiﬁed in our study were pres- Financial support for S.K.B. was provided by the Iranian
ent at different levels in the various tissues studied. Al- government.
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